Suppr超能文献

血管鞘氨醇-1-磷酸梯度——细胞来源及生物学意义

The vascular S1P gradient-cellular sources and biological significance.

作者信息

Hla Timothy, Venkataraman Krishnan, Michaud Jason

机构信息

Center for Vascular Biology, Department of Cell Biology, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06001, USA.

出版信息

Biochim Biophys Acta. 2008 Sep;1781(9):477-82. doi: 10.1016/j.bbalip.2008.07.003. Epub 2008 Jul 28.

Abstract

Sphingosine 1-phosphate (S1P), a product of sphingomyelin metabolism, is enriched in the circulatory system whereas it is estimated to be much lower in interstitial fluids of tissues. This concentration gradient, termed the vascular S1P gradient appears to form as a result of substrate availability and the action of metabolic enzymes. S1P levels in blood and lymph are estimated to be in the muM range. In the immune system, the S1P gradient is needed as a spatial cue for lymphocyte and hematopoietic cell trafficking. During inflammatory reactions in which enhanced vascular permeability occurs, a burst of S1P becomes available to its receptors in the extravascular compartment, which likely contributes to the tissue reactions. Thus, the presence of the vascular S1P gradient is thought to contribute to physiological and pathological conditions. From an evolutionary perspective, S1P receptors may have co-evolved with the advent of a closed vascular system and the trafficking paradigms for hematopoietic cells to navigate in and out of the vascular system.

摘要

鞘氨醇-1-磷酸(S1P)是鞘磷脂代谢的产物,在循环系统中含量丰富,而据估计在组织的间质液中含量要低得多。这种浓度梯度,即所谓的血管S1P梯度,似乎是由于底物可用性和代谢酶的作用而形成的。血液和淋巴中的S1P水平估计在微摩尔范围内。在免疫系统中,S1P梯度作为淋巴细胞和造血细胞迁移的空间线索是必需的。在发生血管通透性增强的炎症反应期间,大量的S1P可作用于血管外区域的受体,这可能有助于组织反应。因此,血管S1P梯度的存在被认为与生理和病理状况有关。从进化的角度来看,S1P受体可能随着封闭血管系统的出现以及造血细胞在血管系统中进出的迁移模式而共同进化。

相似文献

1
The vascular S1P gradient-cellular sources and biological significance.
Biochim Biophys Acta. 2008 Sep;1781(9):477-82. doi: 10.1016/j.bbalip.2008.07.003. Epub 2008 Jul 28.
2
Vascular biology: the role of sphingosine 1-phosphate in both the resting state and inflammation.
J Cell Mol Med. 2010 Sep;14(9):2211-22. doi: 10.1111/j.1582-4934.2010.01136.x.
3
Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors.
Drug News Perspect. 2004 Jul-Aug;17(6):365-82. doi: 10.1358/dnp.2004.17.6.829028.
4
The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate.
Cell Rep. 2012 Nov 29;2(5):1104-10. doi: 10.1016/j.celrep.2012.09.021. Epub 2012 Oct 25.
5
Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient.
Annu Rev Physiol. 2017 Feb 10;79:67-91. doi: 10.1146/annurev-physiol-021014-071635. Epub 2016 Oct 21.
6
Sphingosine 1-phosphate signalling.
Development. 2014 Jan;141(1):5-9. doi: 10.1242/dev.094805.
7
S1P and the birth of platelets.
J Exp Med. 2012 Nov 19;209(12):2137-40. doi: 10.1084/jem.20122284.
8
Relevance and potential of sphingosine-1-phosphate in vascular inflammatory disease.
Biol Chem. 2008 Nov;389(11):1381-90. doi: 10.1515/BC.2008.165.
9
The signalling roles of sphingosine-1-phosphate derived from red blood cells and platelets.
Br J Pharmacol. 2018 Oct;175(19):3741-3746. doi: 10.1111/bph.14451. Epub 2018 Aug 31.
10
Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology.
Pharmacol Res. 2020 Jun;156:104793. doi: 10.1016/j.phrs.2020.104793. Epub 2020 Apr 8.

引用本文的文献

1
Sphingosine 1-phosphate receptor 1 modulators exert neuroprotective effects in central nervous system disorders.
Front Pharmacol. 2025 May 14;16:1516991. doi: 10.3389/fphar.2025.1516991. eCollection 2025.
2
Sphingosine-1-Phosphate Modulation in Neurological Disorders: Insights from MS and Stroke.
Brain Sci. 2025 Apr 24;15(5):436. doi: 10.3390/brainsci15050436.
3
The Multifaceted Impact of Bioactive Lipids on Gut Health and Disease.
Int J Mol Sci. 2024 Dec 20;25(24):13638. doi: 10.3390/ijms252413638.
4
The role of ACER2 in intestinal sphingolipid metabolism and gastrointestinal cancers.
Front Immunol. 2024 Nov 22;15:1511283. doi: 10.3389/fimmu.2024.1511283. eCollection 2024.
5
Association of plasma sphingosine-1-phosphate levels with disease severity and prognosis after intracerebral hemorrhage.
Front Neurol. 2024 Apr 3;15:1365902. doi: 10.3389/fneur.2024.1365902. eCollection 2024.
6
Targeting Sphingosine-1-Phosphate Signaling in Breast Cancer.
Int J Mol Sci. 2024 Mar 15;25(6):3354. doi: 10.3390/ijms25063354.
10
Role of sphingosine 1-phosphate (S1P) in sepsis-associated intestinal injury.
Front Med (Lausanne). 2023 Sep 8;10:1265398. doi: 10.3389/fmed.2023.1265398. eCollection 2023.

本文引用的文献

1
Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype.
Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1454-61. doi: 10.1161/ATVBAHA.107.159392. Epub 2008 Jun 5.
3
Selective activation of G alpha i mediated signalling of S1P3 by FTY720-phosphate.
Cell Signal. 2008 Jun;20(6):1125-33. doi: 10.1016/j.cellsig.2008.01.019. Epub 2008 Feb 1.
4
Functions of sphingolipid metabolism in mammals--lessons from genetic defects.
Biochim Biophys Acta. 2008 Apr;1781(4):145-83. doi: 10.1016/j.bbalip.2008.01.004. Epub 2008 Feb 2.
5
Evolutionary origin of the immune system: a dialogue with Rod Langman.
Scand J Immunol. 2008 Apr;67(4):313-21. doi: 10.1111/j.1365-3083.2008.02075.x. Epub 2008 Feb 9.
6
Vascular endothelium as a contributor of plasma sphingosine 1-phosphate.
Circ Res. 2008 Mar 28;102(6):669-76. doi: 10.1161/CIRCRESAHA.107.165845. Epub 2008 Feb 7.
7
Principles of bioactive lipid signalling: lessons from sphingolipids.
Nat Rev Mol Cell Biol. 2008 Feb;9(2):139-50. doi: 10.1038/nrm2329.
9
Molecular recognition in the sphingosine 1-phosphate receptor family.
J Mol Graph Model. 2008 Jun;26(8):1189-201. doi: 10.1016/j.jmgm.2007.11.001. Epub 2007 Nov 17.
10
S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress.
Immunity. 2008 Jan;28(1):122-33. doi: 10.1016/j.immuni.2007.11.017. Epub 2007 Dec 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验